Hyperglycemia Is Associated With Adverse Outcomes in Patients Receiving Total Parenteral Nutrition
Authors:
- 1 October 2005
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 28 (10) , 2367-2371
Abstract
OBJECTIVE—Hyperglycemia is associated with poor clinical outcomes and mortality in myocardial infarction, stroke, and general hospital patients. However, there are few data regarding the effect of hyperglycemia on outcomes in patients receiving total parenteral nutrition (TPN), a therapy that predisposes patients to hyperglycemia. The aim of this study was to determine whether elevated blood glucose levels are associated with adverse outcomes in patients receiving TPN. RESEARCH DESIGN AND METHODS—A retrospective analysis was undertaken from the medical records of 111 patients (122 treatment episodes) receiving TPN. All patients had blood drawn daily for the measurement of blood glucose levels. Outcome measures were assessed as a function of mean daily blood glucose levels while receiving TPN. RESULTS—Increased blood glucose levels were associated with an increased risk of cardiac complications (odds ratio 1.61, 95% CI 1.09–2.37, P = 0.02), infection (1.4, 1.08–1.82, P = 0.01), systemic sepsis (1.36, 1.00–1.86, P = 0.05), acute renal failure (1.47, 1.00–2.17, P = 0.05), and death (1.77, 1.23–2.52, P < 0.01). When the data were examined by quartiles of blood glucose levels, the mortality of subjects in the highest quartile was 10.9 times (95% CI 2.0–60.5, P < 0.01) that of subjects in the lowest quartile, and the risk of developing any complication was 4.3 times higher (1.4–13.1, P < 0.01). These effects were independent of age, sex, or prior diabetes status. CONCLUSIONS—Hyperglycemia is a predictor of poor outcomes in patients receiving TPN. The confirmation of a relation between blood glucose levels and adverse outcomes provides support for tight glycemic control in these patients.Keywords
This publication has 31 references indexed in Scilit:
- Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in HumansCirculation, 2002
- Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2002
- Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic PatientsStroke, 2001
- Insulin Inhibits Intranuclear Nuclear Factor B and Stimulates I B in Mononuclear Cells in Obese Subjects: Evidence for an Anti-inflammatory Effect?The Journal of Clinical Endocrinology & Metabolism, 2001
- Early Postoperative Glucose Control Predicts Nosocomial Infection Rate in Diabetic PatientsJournal of Parenteral and Enteral Nutrition, 1998
- Glucose Control Lowers the Risk of Wound Infection in Diabetics After Open Heart OperationsThe Annals of Thoracic Surgery, 1997
- Hyperglycemia Associated With High, Continuous Infusion Rates of Total Parenteral Nutrition DextroseNutrition in Clinical Practice, 1996
- Short-term Hyperglycemia Depresses Immunity through Nonenzymatic Glycosylation of Circulating Immunoglobulin1990
- Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitroDiabetes, 1989
- Reversible abnormalities in phagocytic function in poorlycontrolled diabetic patientsThe American Journal of the Medical Sciences, 1972